Pulmonary hypertension in men with thyrotoxicosis

被引:19
|
作者
Soroush-Yari, A [1 ]
Burstein, S [1 ]
Hoo, GWS [1 ]
Santiago, SM [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Dept Med,Pulm & Crit Care Sect, Los Angeles, CA USA
关键词
dyspnea; hyperthyroidism; pulmonary hypertension;
D O I
10.1159/000083408
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Thyrotoxicosis has a myriad of respiratory symptoms including dyspnea. Pulmonary hypertension may contribute to the respiratory symptoms of thyrotoxicosis, but is often unrecognized. We describe 3 male patients with thyrotoxicosis and associated pulmonary hypertension. Case reports of an additional 15 patients are also reviewed. In patients with thyrotoxicosis and pulmonary hypertension, treatment of thyrotoxicosis alone is associated with improvement in pulmonary hypertension. Previous reports have consisted of mostly female patients, but we report 3 men. When all cases are considered, the typical patient is female (10/14 = 71%), middle-aged ( 48 years), with mean pulmonary artery systolic pressures improving from 56 to 32 mm Hg with treatment. Autoantibodies were detected in 10/14 ( 71%) patients. The response to treatment ( medical or surgical) of thyrotoxicosis supports the hypothesis that hyperthyroidism is either a cause of pulmonary hypertension, or a factor that may unmask pulmonary hypertension. Recognition is important since treatment and response are very different compared to other patients with pulmonary hypertension. This association may not be readily considered in men, since most reports have been of women. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 50 条
  • [1] Thyrotoxicosis and pulmonary hypertension
    Ma, RC
    Cheng, AY
    So, WY
    Hui, DS
    Tong, PC
    Chow, CC
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08): : 927 - 928
  • [2] Pulmonary hypertension and thyrotoxicosis
    Conradie, M.
    Koegelenberg, C.
    Conradie, M.
    Ascott-Evans, B. H.
    Hough, F. S.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2012, 17 (02) : 101 - 104
  • [3] AMIODARONE THYROTOXICOSIS LEADING TO PULMONARY HYPERTENSION
    Khan, Nauman A.
    Mira-Avendano, Isabel C.
    CHEST, 2022, 162 (04) : 2341A - 2341A
  • [4] Pulmonary Hypertension and Hypocholesterolemia Secondary to Thyrotoxicosis
    Shyamali, Narangoda Liyanage Ajantha
    Ponnamperuma, Chandrike
    CASE REPORTS IN ENDOCRINOLOGY, 2020, 2020
  • [5] Thyrotoxicosis as a risk factor for pulmonary arterial hypertension
    Ma, RC
    Chow, CC
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (03) : 222 - 222
  • [6] Cholestasis and Pulmonary Hypertension in Neonatal Thyrotoxicosis: A Case Report
    Ehab Mohamed Hantash
    Manar Hany Anwar
    Syeda Naqvi
    Maha Musri Alzubyania
    Abdulrahman Abdullah Al Zahrani
    Dr. Sulaiman Al Habib Medical Journal, 2022, 4 (4) : 205 - 208
  • [7] Pulmonary hypertension and predominant right heart failure in thyrotoxicosis
    Paran, Yael
    Nimrod, Adi
    Goldin, Yelena
    Justo, Dan
    RESUSCITATION, 2006, 69 (02) : 339 - 341
  • [8] Right ventricular dysfunction and pulmonary hypertension: a neglected presentation of thyrotoxicosis
    Singarayar, Carolina Shalini
    Hui, Foo Siew
    Cheong, Nicholas
    En, Goay Swee
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2018,
  • [9] THYROTOXICOSIS SECONDARY TO ALEMTUZUMAB TREATMENT FOR MULTIPLE SCLEROSIS PRESENTING AS PULMONARY HYPERTENSION
    Healy, S.
    Willis, M. D.
    Pickersgill, T. P.
    Page, M.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [10] Neonatal thyrotoxicosis and persistent pulmonary hypertension necessitating extracorporeal life support
    Oden, J
    Cheifetz, IM
    PEDIATRICS, 2005, 115 (01) : E105 - E108